COVAXIN For Children in 6-12 Age Group: AIIMS Delhi To Begin Recruiting for Clinical Trials of Single Dose of Bharat Biotech COVID-19 Vaccine

COVAXIN For Children in 6-12 Age Group: AIIMS Delhi To Begin Recruiting for Clinical Trials of Single Dose of Bharat Biotech COVID-19 Vaccine

AIIMS Delhi will begin recruiting for clinical trials on children aged 6 to 12 tomorrow, followed by children aged 2 to 6. The trial for the 6-12 age group will begin tomorrow. The recruitment and clinical trial for single-dose COVAXIN for children aged 12 to 18 have concluded.

— Prasar Bharati News Services पी.बी.एन.एस. (@PBNS_India) June 14, 2021

(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)